Eli Lilly East SA,   Switzerland

Antitumor agent, antimetabolite.
Lyophilizate for the preparation of a solution for infusions of 100 mg in a vial.
Antitumour agent, antimetabolite
Lyophilizate for the preparation of a solution for infusions of 100 mg in a vial.
Antibiotic glycopeptide
Lyophilizate for solution for infusion, 500 mg.
Antitumour agent, antimetabolite
Lyophilizate for the preparation of a solution for infusions of 200 mg or 1 g.
Antipsychotic agent (antipsychotic)

In the case of Eli Lilly and Company Limited, UK, it is stated:

Tablets, film-coated, 2.5 mg, 5 mg, 7.5 mg and 10 mg.

In the case of the production of Lilly SA, Spain or Lilly del Caribe Inc., Puerto Rico, it is indicated:

Tablets, film-coated, 5 mg and 10 mg.

Antipsychotic agent (antipsychotic)
Lyophilizate for the preparation of solution for intramuscular injection.
antipsychotic agent (antipsychotic)

Powder for suspension for intramuscular injection 210 mg, 300 mg or 405 mg complete with a solvent.

Antipsychotic agent (antipsychotic)

Tablets are dispersible, 5 mg, 10 mg.

antidepressant
capsules 20 mg
Antiaggregant agent
Solution for intravenous administration of 2 mg / ml in vials.
Erectile dysfunction remedy, PDE-5 inhibitor.

Tablets, film-coated 2.5 mg, 5 mg.

For 14 tablets in a blister, consisting of aluminum laminated foil and PVC / PE / PCTFE film. For 1 or 2 blisters, together with the instructions for use, put in a pack of cardboard.

antidepressant
Capsules intestinal soluble 30 mg or 60 mg.
Sympathomimetic means of central action.

Capsules 10 mg, 18 mg, 25 mg, 40 mg and 60 mg.

hypoglycemic agent - a glucagon-like receptor polypeptide agonist

A solution for subcutaneous administration, 0.75 mg / 0.5 ml or 1.5 mg / 0.5 ml.

The parathyroid hormone is analogous.

A solution for subcutaneous administration of 250 μg / ml in a 3 ml syringe pen. and 2.4 ml. One syringe pen together with the instruction for use of the drug and the Manual on the use of the syringe pen in a pack of cardboard.

hypoglycemic agent - short-acting insulin analog
Solution for intravenous and subcutaneous administration, 100 IU / ml.
Hypoglycemic agent is a combination of insulin analogues of short and medium duration of action

Suspension for subcutaneous administration, 100 IU / ml.

Hypoglycemic agent is a combination of insulin analogues of short and medium duration of action
Suspension for subcutaneous administration, 100 IU / ml.
hypoglycemic agent - a combination of insulin of short and medium duration of action

Suspension for subcutaneous administration, 100 IU / ml.

hypoglycemic agent - medium-duration insulin

Suspension for subcutaneous administration, 100 IU / ml.

hypoglycemic agent - short-acting insulin

Solution for injection, 100 IU / ml.

Antineoplastic agents, monoclonal antibodies

Concentrate for the preparation of a solution for infusions of 10 mg / ml.

antiplatelet agent

Tablets, film-coated, 5 mg and 10 mg.